Original explanatory diagram
AlphaGenome mapped regulatory predictions without becoming a clinical result
Google DeepMind introduced AlphaGenome in June 2025 for regulatory variant-effect research, combining long DNA input with multi-modal molecular predictions and research limits.
Read analysis